If FoB's follow the 20% or so discount to the branded product that would still seem attractive pricing potential for HIF drugs with the added benefit of being Oral, maybe alleviate the need for Iron and possible safety advantage.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.